再获肯定！以岭药业创新研发成果被巴西旅游厅厅长高度赞扬

Core Insights - The Brazilian government official praised Yiling Pharmaceutical for its contributions to global health through innovative research and development, highlighting the company's international influence and innovation capabilities [1][3] Group 1: Innovation and R&D - Yiling Pharmaceutical has consistently prioritized "technological innovation" as its core development strategy, establishing a unique research system based on "network disease theory" [3] - The company maintains an annual R&D output of 1-2 new drugs, with a total of 17 innovative patented traditional Chinese medicine products currently on the market [3] - Yiling has developed a product matrix addressing major diseases such as cardiovascular and respiratory conditions [3] Group 2: International Expansion - Yiling Pharmaceutical actively promotes its products internationally, with core products registered and marketed in over 50 countries and regions [3] - The company emphasizes "technical communication" and "standard alignment" in its international collaborations, achieving certifications from various global regulatory bodies such as EU GMP, Malaysia NPRA, and Brazil ANVISA [3] - Yiling collaborates with overseas research and medical institutions to advance the dissemination of network disease theory and traditional Chinese medicine research in the international academic community [3] Group 3: Future Outlook - The practices of Yiling Pharmaceutical not only demonstrate the innovation strength of Chinese pharmaceutical companies but also provide a replicable path for traditional Chinese medicine to enter the global market [3] - With the increasing global demand for traditional medicine, Yiling is expected to continue focusing on R&D innovation and internationalization to contribute to the construction of a global health community [3]